IP Verse

Crystalline Forms Of (S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-Methyl-1H-Pyrazol-4-Yl)Pyrrolo[2,1-F][1,2,4]Triazin-4-Yl)Piperazinyl)-Pyrimidin-5-Yl)Ethan-1-Amine And Methods Of Making - EP3856341

The patent EP3856341 was granted to Blueprint Medicines on Sep 6, 2023. The application was originally filed on Apr 10, 2020 under application number EP20722936A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3856341

BLUEPRINT MEDICINES
Application Number
EP20722936A
Filing Date
Apr 10, 2020
Status
Granted And Under Opposition
Aug 4, 2023
Grant Date
Sep 6, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBJun 5, 2024ADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2014039714
DESCRIPTIONWO2014100620
DESCRIPTIONWO2015057873
INTERNATIONAL-SEARCH-REPORTWO2015057873
OPPOSITIONWO2015057873
OPPOSITIONWO2021004895

Non-Patent Literature (NPL) Citations (24) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BERGE, S.M. et al., J. Pharma. Sci., (19770000), vol. 66, pages 1 - 19-
DESCRIPTION- CHABOT, B. et al., Nature, (19880000), vol. 335, no. 6185, pages 88 - 9-
DESCRIPTION- GARCIA-MONTERO, A.C. et al., Blood, (20060000), vol. 108, no. 7, pages 2366 - 72-
DESCRIPTION- GULEN, T. et al., J Intern Med., (20160000), vol. 279, no. 3, pages 211 - 28-
DESCRIPTION- JENNINGS, S. et al., J Allergy Clin Immunol., (20140000), vol. 2, no. 1, pages 70 - 76-
DESCRIPTION- LIM, K.H. et al., Blood, (20090000), vol. 113, no. 23, pages 5727 - 36-
DESCRIPTION- SIEBENHAAR, F. et al., Allergy, (20160000), vol. 71, no. 6, pages 869 - 77-
DESCRIPTION- VALENT, P., Am J Cancer Res., (20130000), vol. 3, no. 2, pages 159 - 72-
DESCRIPTION- VALENT, P. et al., Blood, (20170000), vol. 129, no. 11, pages 1420 - 27-
DESCRIPTION- VERSTOVSEK, S., Eur J Haematol., (20130000), vol. 90, no. 2, pages 89 - 98-
DESCRIPTION- WHYNES, D.K., Health Qual Life Outcomes, (20080000), vol. 6, page 94-
INTERNATIONAL-SEARCH-REPORT- Hilfiker R., Blatter F., von Raumer M., "Relevance of solid-state properties for pahrmaceutical products", Hilfiker R., Blatter F., von Raumer M., HILFIKER R (EDITOR) ED - HILFIKER R, Polymorphism in the Pharmaceutical Industry, Wiley-VCH, (200601), pages 1 - 19, ISBN 3-527-31146-7, XP002528052 [Y] 1-38 * abstract * * pages 6-14, paragraphs 1.3., 1.4. *-
INTERNATIONAL-SEARCH-REPORT- MINO R CAIRA ED - MONTCHAMP JEAN-LUC, "Crystalline Polymorphism of Organic Compounds", TOPICS IN CURRENT CHEMISTRY; [TOPICS IN CURRENT CHEMISTRY], SPRINGER, BERLIN, DE, vol. 198, doi:10.1007/3-540-69178-2_5, ISSN 0340-1022, (199801), pages 163 - 208, (19990226), XP008166276 [Y] 1-38 * abstract * * bridging paragraph *; pages 165-166 * * pages 177-180, paragraph 3.1. *
OPPOSITION- Anonymous, "2.9.33. - Characterisation of Crystalline and Partially Crystalline Solids by X-Ray Powder Diffraction (XRPD)", European Pharmacopeia 7.0, (20090101), pages 301 - 305, XP055582946-
OPPOSITION- Anonymous, "Blopharmazie", Anonymous, Bearbeitet von Bernhard C. , Lippold Christel Muller-Goymann Rolf Schubert, LEHRBUCH DER PHARMAZEUTISCHEN TECHNOLOGIE, Wissenschaftliche Verlagsgesellschaft mbH Stuttgart, (20060101), pages 214 - 217, ISBN 978-3-8047-2222-4, XP093192597-
OPPOSITION- Bavin Mike, "Polymorphism in Process Development", Chemistry & Industry, (19890821), pages 527 - 529, XP093192606-
OPPOSITION- Bu ̈ttner Claudia, Beate M. Henz, Pia Welker, Norbert T. Sepp, Jurgen Grabbe, "Identification of Activating c-kit Mutations in Adult-, but not in Childhood-Onset Indolent Mastocytosis: A Possible Explanation for Divergent Clinical Behavior", Journal of Investigative Dermatology, (19981201), vol. 111, no. 6, pages 1227 - 1231, XP093192586-
OPPOSITION- D12 - Declaration of Verena Adamer-
OPPOSITION- Guillory J. Keith, "5. Generation of Polymorphs, Hydrates, Solvates, and Amorphous Solids", Polymorphism in Pharmaceutical solids ED. 2, US, INFORMA HEALTHCARE , (19990101), pages 183 - 226, ISBN 0-8247-0237-9, XP093151406-
OPPOSITION- GUILLORY J K, "GENERATION OF POLYMORPHS, HYDRATES, SOLVATES, AND AMORPHOUS SOLIDS", GUILLORY J K, Harry G. Brittain (ed.), Polymorphism in Pharmaceutical solids, USA , M. Dekker , (19990101), pages I - II + 183 - 226, ISBN 978-0-8247-0237-3, XP002350313-
OPPOSITION- Sisir Bhattacharya, Harry G. Brittain, Raj Suryanarayanan, "Chapter 9: Thermoanalytical and Crystallographic Methods", Sisir Bhattacharya, Harry G. Brittain, Raj Suryanarayanan, Harry G Brittain, Polymorphism in Pharmaceutical solids ED. 2, US, INFORMA HEALTHCARE , (20090727), pages 319 - 346, ISBN 0-8247-0237-9, XP009555933-
OPPOSITION- Alfons Grunenberg, "Polymorphie und Thermische Analyse pharmazeutischer Wirkstoffe", Pharmazie in unserer Zeit, (19970101), vol. 26, no. 5, doi:10.1002/pauz.19970260506, pages 224 - 231, XP055745450
OPPOSITION- Stephen Byrn, Ralph Pfeiffer, Michael Ganey, Charles Hoiberg and Guirag Poochikian, "Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950701), vol. 12, no. 7, doi:10.1023/A:1016241927429, pages 945 - 954, XP055531015
OPPOSITION- Oppelt Peter J., Hirbe Angela C., Van Tine Brian A., "Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review", Journal of Gastrointestinal Oncology, (20170601), vol. 8, no. 3, doi:10.21037/jgo.2016.09.15, ISSN 2078-6891, pages 466 - 473, XP093192590

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents